Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Person › Details

Angelika Lüking (Protagen AG)

Lüking, Angelika (Protagen 201009 Head R&D)

 

Organisation Organisation Protagen AG
Products Product UNIarray® technology
  Product 2 proteomic services
     

Protagen AG. (9/23/10). "Press Release: Protagen at the Biotechnica 2010". Dortmund.

Protagen AG, a specialist for GMPcompliant protein analysis and in-vitro diagnostics is presenting at the Biotechnica conference 2010 in Hanover. The experts of the company will provide insights into the latest developments of GMP-compliant protein analysis and applications of the UNIarray® technology platform.

UNIarray® serves as a unique technology platform to develop and validate novel, serum based molecular diagnostics and can be further applied in the development of biomarkers for therapy monitoring and companion diagnostics.

In-house research at Protagen is currently focused on the validation of proprietary biomarker panels for the diagnosis of Prostate Cancer and Multiple Sclerosis. Additional R&D activities are concentrating on Breast, Ovarian and Pancreas Cancer, as well as Morbus Parkinson, Rheumatoid Arthritis and Systemic Lupus Erythematodes.

Dr. Schulz-Knappe, CSO at Protagen AG will be presenting an update on the Prostate Cancer validation study at the Molecular Diagnostics Europe Conference (MDxEU), which will be co-hosted parallel to the Biotechnica meeting (5.10.2010 at 11.45 am. For further information please refer to www.moleculardiagnosticseu.com/mxe).

In addition, Dr. Angelika Lüking, Head of Research and Development at Protagen AG will be presenting an update on the Multiple Sclerosis program at the BMBF project forum (5.10. 2010 at 11.30 am, BMBF Forum).

You are cordially invited to meet us at the Biotechnica Partnering event or you can visit us at the BioNRW booth (Hall 9, E 16).


About Protagen AG

Protagen AG (www.protagen.de) is an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis. The innovations of Protagen are UNIarray®, a technology platform for the development of novel serum based diagnostics, as well as UNIchip®, a versatile product family of protein microarrays for faster development of antibodies.

Contact

Media Enquiries
Dr. Stefan Müllner
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: info@protagen.de

Bettina Franz
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: bettina.franz@protagen.de

   
Record changed: 2017-04-09

Advertisement

Picture [LSS] Life-Sciences-Scandinavia.com – The Business Web Portal 560x95px


More documents for Angelika Lüking


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px




» top